PFIZER Gains $4.9 Billion Contract Modification
Copyright © Targeted News Service 2022
2022-09-13
WASHINGTON, Sept. 13 -- The U.S. Army issued the following high-value contract information through the Pentagon on Sept. 7, 2022. PFIZER INC., New York, New York, was awarded a $4,852,867,500 modification to contract (W58P05-22-C-0001) for the oral therapeutic PAXLOVID. Work will be performed in New York. The U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity.[DODBT] . . .
